Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel versus aspirin anti-inflammatory effects in chronic ischemic cardiomyopathy
2006-000001-27Phase 3Completed
- Sponsor
- Universitäts-Herzzentrum Freiburg-Bad Krozingen
- Start
- May 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clopidogrel and aspirin in ischaemic cardiomyopathy (ICM) (2 arms), sponsored by Universitäts-Herzzentrum Freiburg-Bad Krozingen. Primary endpoint: Primary endpoint not specified. Started May 2007; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on 2006-000001-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000001-27.